FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/08/035912 [Registered on: 25/08/2021] Trial Registered Prospectively
Last Modified On: 08/06/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To compare the different laryngoscopes king vision, Mac coy and Macintosh laryngoscopes for tracheal intubation in cases of mucormycosis scheduled for surgery. 
Scientific Title of Study   Comparative evaluation of King version video-laryngoscope, Mac-Coy and Macintosh laryngoscopes for tracheal intubation in patients scheduled for mucormycosis surgery in a tertiary care hospital. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Michell Gulabani 
Designation  Assistant professor 
Affiliation  Department of anaesthesia UCMS/GTBH 
Address  Department of Anaesthesia University college of Medical Sciences Guru Teg Bahadur Hospital Delhi
Department of Anaesthesia University college of Medical Sciences Guru Teg Bahadur Hospital Delhi
East
DELHI
110017
India 
Phone  9873657500  
Fax    
Email  michellgulabani@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Michell Gulabani 
Designation  Assistant professor 
Affiliation  Department of anaesthesia UCMS/GTBH 
Address  Department of Anaesthesia University College of Medical Sciences Guru Tekh Bahadur Hospital Delhi
Department of Anaesthesia University College of Medical Sciences Guru Tekh Bahadur Hospital Delhi
East
DELHI
110017
India 
Phone  9873657500  
Fax    
Email  michellgulabani@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Michell Gulabani 
Designation  Assistant professor 
Affiliation  Department of anaesthesia UCMS/GTBH 
Address  Department of Anaesthesia University College Of Medical Sciences Guru Tekh Bahadur Hospital Delhi
Department of Anaesthesia University College Of Medical Sciences Guru Tekh Bahadur Hospital Delhi
East
DELHI
110017
India 
Phone  9873657500  
Fax    
Email  michellgulabani@gmail.com  
 
Source of Monetary or Material Support  
University college of medical sciences Guru Tekh bahadur Hospital Delhi  
 
Primary Sponsor  
Name  UCMSGTBH 
Address  Dilshad garden Delhi 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Michell Gulabani  UCMS/GTBH  Department of Anaesthesia UCMS
East
DELHI 
09873657500

michellgulabani@gmail.com 
Dr Michell Gulabani  UCMS/GTBH  Operation theatre for Mucormycosis surgery
East
DELHI 
09873657500

michellgulabani@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics Committe /HR- UCMS  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical, (2) ICD-10 Condition: B488||Other specified mycoses, (3) ICD-10 Condition: B488||Other specified mycoses,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Comparasion of King vision, Mac Coy and Macintosh laryngoscopes for tracheal intubation of patients posted for Mucormycosis surgery  A structured questionnaire as enclosed as patient record form (Annexure 1) will be used for recording the airway and hemodynamic data. Patients in the A group will be intubated with King ‘s vision video laryngoscope , those belonging to Group B Mc Coy laryngoscope will be used and in Group C Macintosh laryngoscope after induction of anesthesia. . On shifting the patient to the operation theater, all the monitoring devices shall be attached. An 18 G IV infusion line will be started, and all patients shall be hydrated with approximately 8-10 ml/kg of normal saline before induction. All hemodynamic data will be measured on arrival in OT, before induction, after induction, and at 1, 2, 3, 5 and 7 minutes after intubation by an independent observer. Anesthesia will be induced with Injection propofol till the loss of response to verbal commands and fentanyl 2μg/kg. After giving injection succinylcholine 2mg/kg and ventilating the patients with O2 100% for 60 seconds , laryngoscope depending on the group will be used and intubation shall be performed by an experienced anesthesiologist with cuffed oral endotracheal tube . 
Comparator Agent  Comparative evaluation of King vision video-laryngoscope, Mac-Coy and Macintosh laryngoscopes for tracheal intubation in patients scheduled for mucormycosis surgery in a tertiary care hospital: A prospective randomized study.  A complete Pre-anesthetic checkup including complete airway assessment based on standard indices will be performed prior to their scheduled allotment into the three different study groups. Patients will be randomly allocated to the three groups by a computer generated random number table after obtaining written and informed consent. A structured questionnaire as enclosed as patient record form (Annexure 1) will be used for recording the airway and hemodynamic data. Patients in the A group will be intubated with King ‘s vision video laryngoscope , those belonging to Group B Mc Coy laryngoscope will be used and in Group C Macintosh laryngoscope after induction of anesthesia. . On shifting the patient to the operation theater, all the monitoring devices shall be attached. An 18 G IV infusion line will be started, and all patients shall be hydrated with approximately 8-10 ml/kg of normal saline before induction. All hemodynamic data will be measured on arrival in OT, before induction, after induction, and at 1, 2, 3, 5 and 7 minutes after intubation by an independent observer. Anesthesia will be induced with Injection propofol till the loss of response to verbal commands and fentanyl 2μg/kg. After giving injection succinylcholine 2mg/kg and ventilating the patients with O2 100% for 60 seconds , laryngoscope depending on the group will be used and intubation shall be performed by an experienced anesthesiologist with cuffed oral endotracheal tube . 
Comparator Agent  Laryngoscopes  3 GROUPS will be compared depending on the type of laryngoscope used . King vision, Mac Coy and Macintosh laryngoscopes 
Intervention  nil  nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  All ASA1 and ASA2 patients in the age group of 18- 65 years will be included in this prospective randomized study. 
 
ExclusionCriteria 
Details  1 Morbid Obesity
2 Pregnancy
3 Bleeding diathesis
4 Severe cardiac or respiratory insufficiency
5 Progressive neurological disease 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Mouth opening after induction, Cormack- Lehane grade, time to successful intubation, number of attempts, any adjuncts used for airway optimization  Hemodynamic variables before induction, after induction, 1,2, 3, 5 and 7 minutes after intubation 
 
Secondary Outcome  
Outcome  TimePoints 
Hemodynamic variables like heart rate, systolic blood pressure, diastolic blood pressure, mean blood pressure , ECG and SP02  Pre induction, post induction, 1, 2, 3, 5, 7 minutes of intubation 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "90"
Final Enrollment numbers achieved (India)="90" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/09/2021 
Date of Study Completion (India) 31/08/2021 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="3"
Days="30" 
Recruitment Status of Trial (Global)
Modification(s)  
Completed 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
published 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  

Mucormycosis ,an emerging  angioinvasive fungal infection is associated with high morbidity and mortality. Rhino orbital cerebral mucormycosis (ROCM) is  characterised by progressive fungal invasion of the hard palate, paranasal sinuses, orbit, and brain is the commonest variant..

Patients  with ROCM , may experience difficult mask ventilation and endotracheal intubation as a result of epiglottitis and supraglottic edema associated with fungal debris.

The armamentarium of the anesthesiologist has a variety of options for difficult intubation . King vision video laryngoscope is one of the latest laryngoscopes as an aid in difficult airway.

 

However, relative efficacy of this device in comparison with the Macintosh laryngoscope and Mc Coy laryngoscope  has not been compared in mucormycosis patients. Therefore, this randomized, prospective study will be planned to compare the effectiveness of Macintosh, McCoy, and King Vision video laryngoscopes to compare the ease of intubation  and hemodynamic variables in mucormycosis patients posted for elective surgery .

 

90 consenting adult patients aged 18-65 years of age of either sex ASA Grade 1 and ASA Grade 2 undergoing elective surgery under general anesthesia with endotracheal intubation will be included in this prospective  randomized study protocol.

 

The end points of the primary objectives are  Mouth opening post induction, Cormack-Lehane grade, time to successful intubation and number of attempts to successful intubation.The  secondary objectives will be a heart Rate, Systolic blood pressure and diastolic blood pressure.

Patients in the A group will be intubated with King ‘s vision video laryngoscope , those belonging to Group B Mc Coy laryngoscope will be used and in Group C Macintosh laryngoscope after induction of anesthesia.

Sample size will be calculated at 95 % significance level and power of 80%.  An alpha error of 0.05 and beta error of 0.2 incorporating three equal size groups of 30 each will be taken. The total number of patients being enrolled will be 90.

The second wave of the COVID 19 pandemic has seen a surge in the cases of mucormycosis and hence optimal anesthetic management of patients being scheduled for anaesthesia is vital.

 

 

 

 

 

 
Close